SOPH insider trading — SOPHiA Genetics SA
Over the last 90 days, insiders at SOPHiA Genetics SA (SOPH) made 0 open-market purchases worth $0 and 2 open-market sales worth $41K, making them net sellers by $41K. The largest sale was by Menu Philippe (Chief Medical Officer), who sold 5,000 shares for $39K on Sep 14, 2026.
Updated Oct 16, 2026.
Recent SOPH insider transactions
Every Form 4 filed by SOPHiA Genetics SA officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | Menu Philippe | Chief Medical Officer | S · Sale · 10b5-1 | Direct | 5,000 | $7.26 | $36K | Form 4 |
| Oct 13, 2026 | Xu Zhenyu | Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 4,000 | $7.18 | $29K | Form 4 |
| Oct 12, 2026 | Camblong Jurgi | Executive Chairman | S · Sale · 10b5-1 | Direct | 8,500 | $7.26 | $62K | Form 4 |
| Oct 5, 2026 | Cardoza George | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 1,592 | $8.10 | $13K | Form 4 |
| Oct 5, 2026 | Xu Zhenyu | Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 7,394 | $8.12 | $60K | Form 4 |
| Oct 5, 2026 | Menu Philippe | Chief Medical Officer | S · Sale · 10b5-1 | Direct | 7,394 | $8.13 | $60K | Form 4 |
| Oct 5, 2026 | Camblong Jurgi | Executive Chairman | S · Sale · 10b5-1 | Direct | 40,172 | $8.13 | $327K | Form 4 |
| Oct 5, 2026 | Van Well Daan | Chief Legal Officer | S · Sale · 10b5-1 | Direct | 6,168 | $8.12 | $50K | Form 4 |
| Oct 5, 2026 | Puylaert Kevin | Chief Sales Officer | S · Sale | Direct | 216 | $8.04 | $2K | Form 4 |
| Oct 5, 2026 | Verma Abhimanyu | Chief Technology Officer | S · Sale · 10b5-1 | Direct | 5,284 | $8.12 | $43K | Form 4 |
| Oct 5, 2026 | Valente Manuela | Chief People Officer | S · Sale · 10b5-1 | Direct | 4,240 | $8.13 | $34K | Form 4 |
| Oct 5, 2026 | Muken Ross | Chief Executive Officer | S · Sale · 10b5-1 | Direct | 9,838 | $8.13 | $80K | Form 4 |
| Sep 21, 2026 | Cardoza George | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 774 | $8.33 | $6K | Form 4 |
| Sep 21, 2026 | Muken Ross | Chief Executive Officer | S · Sale · 10b5-1 | Direct | 422 | $8.33 | $4K | Form 4 |
| Sep 14, 2026 | Xu Zhenyu | Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 4,000 | $7.88 | $32K | Form 4 |
| Sep 14, 2026 | Menu Philippe | Chief Medical Officer | S · Sale | Direct | 5,000 | $7.88 | $39K | Form 4 |
| Sep 11, 2026 | Van Well Daan | Chief Legal Officer | S · Sale · 10b5-1 | Direct | 6,168 | $7.63 | $47K | Form 4 |
| Sep 10, 2026 | Camblong Jurgi | Executive Chairman | S · Sale · 10b5-1 | Direct | 8,500 | $7.66 | $65K | Form 4 |
| Sep 8, 2026 | Hibbs Kathy L | Director | S · Sale · 10b5-1 | Direct | 6,250 | $8.13 | $51K | Form 4 |
| Aug 27, 2026 | Xu Zhenyu | Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 10,000 | $8.91 | $89K | Form 4 |
| Aug 25, 2026 | Hibbs Kathy L | Director | S · Sale · 10b5-1 | Direct | 6,250 | $8.68 | $54K | Form 4 |
| Aug 25, 2026 | Menu Philippe | Chief Medical Officer | S · Sale · 10b5-1 | Direct | 5,000 | $8.68 | $43K | Form 4 |
| Aug 24, 2026 | Verma Abhimanyu | Chief Technology Officer | S · Sale · 10b5-1 | Direct | 5,000 | $8.80 | $44K | Form 4 |
| Aug 19, 2026 | Verma Abhimanyu | Chief Technology Officer | S · Sale · 10b5-1 | Direct | 5,000 | $8.20 | $41K | Form 4 |
| Aug 19, 2026 | Valente Manuela | Chief People Officer | M · Option exercise · 10b5-1 | Direct | 10,000 | $3.20 | $32K | Form 4 |
| Aug 19, 2026 | Valente Manuela | Chief People Officer | S · Sale · 10b5-1 | Direct | 10,000 | $7.94 | $79K | Form 4 |
| Aug 21, 2026 | Xu Zhenyu | Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 5,408 | $8.40 | $45K | Form 4 |
| Aug 20, 2026 | Xu Zhenyu | Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 4,592 | $8.41 | $39K | Form 4 |
| Aug 19, 2026 | Xu Zhenyu | Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 10,000 | $7.94 | $79K | Form 4 |
| Aug 13, 2026 | Xu Zhenyu | Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 4,000 | $7.52 | $30K | Form 4 |
| Aug 12, 2026 | Menu Philippe | Chief Medical Officer | S · Sale · 10b5-1 | Direct | 5,000 | $7.52 | $38K | Form 4 |
| Aug 10, 2026 | Camblong Jurgi | Executive Chairman | S · Sale · 10b5-1 | Direct | 8,500 | $7.61 | $65K | Form 4 |
| Aug 7, 2026 | Camblong Jurgi | Executive Chairman | S · Sale · 10b5-1 | Direct | 20,000 | $7.23 | $145K | Form 4 |
| Aug 7, 2026 | Verma Abhimanyu | Chief Technology Officer | S · Sale · 10b5-1 | Direct | 5,000 | $7.60 | $38K | Form 4 |
| Aug 7, 2026 | Xu Zhenyu | Chief Scientific Officer | M · Option exercise · 10b5-1 | Direct | 7,000 | $3.28 | $23K | Form 4 |
| Aug 7, 2026 | Xu Zhenyu | Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 17,000 | $7.29 | $124K | Form 4 |
| Aug 5, 2026 | Xu Zhenyu | Chief Scientific Officer | M · Option exercise · 10b5-1 | Direct | 3,000 | $3.28 | $10K | Form 4 |
| Aug 5, 2026 | Xu Zhenyu | Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 3,000 | $7.00 | $21K | Form 4 |
| Aug 4, 2026 | Camblong Jurgi | Executive Chairman | S · Sale · 10b5-1 | Direct | 20,000 | $6.92 | $138K | Form 4 |
| Aug 4, 2026 | Verma Abhimanyu | Chief Technology Officer | S · Sale · 10b5-1 | Direct | 5,000 | $6.95 | $35K | Form 4 |
| Aug 4, 2026 | Xu Zhenyu | Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 10,000 | $6.92 | $69K | Form 4 |
| Jul 27, 2026 | Menu Philippe | Chief Medical Officer | S · Sale · 10b5-1 | Direct | 5,000 | $5.66 | $28K | Form 4 |
| Jul 21, 2026 | Camblong Jurgi | Executive Chairman | S · Sale · 10b5-1 | Direct | 20,000 | $6.63 | $133K | Form 4 |
| Jul 20, 2026 | Camblong Jurgi | Executive Chairman | S · Sale · 10b5-1 | Direct | 24,381 | $6.29 | $153K | Form 4 |
| Jul 20, 2026 | Camblong Jurgi | Executive Chairman | M · Option exercise · 10b5-1 | Direct | 4,581 | $3.16 | $14K | Form 4 |
SOPH insider trading FAQ
Are insiders buying SOPH stock?
Not on the open market. In the last 90 days, SOPHiA Genetics SA insiders made no open-market purchases, and 2 open-market sales totaling $41K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading SOPH?
Recent sellers: Menu Philippe, Puylaert Kevin.
Where does SOPH insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.